glycerol has been researched along with metformin in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (23.81) | 18.7374 |
1990's | 4 (19.05) | 18.2507 |
2000's | 7 (33.33) | 29.6817 |
2010's | 4 (19.05) | 24.3611 |
2020's | 1 (4.76) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Alberti, KG; Betteridge, DJ; Cudworth, AG; De Silva, SR; Shawe, JE | 1 |
Benzi, L; Brunetti, P; Cecchetti, P; Di Carlo, A; Di Cianni, G; Giannarelli, R; Gregorio, F; Marchetti, P; Navalesi, R; Villani, G | 1 |
Baty, J; Isles, TE; Jung, RT; Leslie, P | 1 |
Disilvio, L; Featherbe, D; Hawa, MI; Jackson, RA; Jaspan, JB; Kurtz, AB; Sim, BM | 1 |
Jalling, O; Olsen, C | 1 |
Curtis-Prior, PB | 1 |
Campagnolo, M; Ceolotto, G; Da Tos, V; Del Prato, S; Dorella, M; Felice, M; Giusto, M; Palatini, P; Rossi, G; Semplicini, A | 1 |
Andersson, OK; Gudbjörnsdóttir, HS; Jansson, PA; Lönnroth, PN | 1 |
Adler, G; Alt, A; Ditschuneit, HH; Flechtner-Mors, M; Jenkinson, CP | 1 |
Cherrington, AD; Chu, CA; Knauf, M; Muscato, N; Neal, DW; Wiernsperger, N | 1 |
Hansen, SH; McCormack, JG | 1 |
Cleasby, ME; Cooney, GJ; Dzamko, N; Furler, SM; Hegarty, BD; Kraegen, EW; Ye, JM | 1 |
Basu, A; Basu, R; Chandramouli, V; Cohen, O; Dicke, B; Landau, BR; Norby, B; Rizza, RA; Shah, P | 2 |
Guo, X; He, J; Jiang, H; Pu, S; Xu, C; Xu, G; Zhang, T; Zu, L | 1 |
Cherrington, AD; Donahue, EP; Lacy, B; Printz, RL; Sasaki, N; Shiota, M; Torres, TP; Treadway, JL | 1 |
Dungan, CM; Frendo-Cumbo, S; Mennes, E; Williamson, DL; Wright, DC | 1 |
Cai, J; Hu, H; Huang, M; Li, Y; Song, J; Tian, N; Wang, Y; Wu, C; Xing, Q | 1 |
Butrico, GM; Cline, GW; Gaspar, RC; Goedeke, L; Hubbard, BT; Hüttemann, M; Kalpage, HA; LaMoia, TE; Nakahara, K; Shimada, A; Shulman, GI; Vatner, DF; Woo, S; Zhang, XM | 1 |
3 trial(s) available for glycerol and metformin
Article | Year |
---|---|
Metformin and clofibrate in maturity onset diabetes mellitus: advantages of combined treatment.
Topics: Alanine; Blood Glucose; Cholesterol; Circadian Rhythm; Clofibrate; Diabetes Mellitus; Drug Synergism; Fibrinogen; Glycerol; Humans; Hydroxybutyrates; Lactates; Lipoproteins; Metformin; Triglycerides | 1979 |
Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance.
Topics: Adult; Aged; Alanine; Aldosterone; Blood Glucose; Blood Pressure; Body Weight; Cross-Over Studies; Double-Blind Method; Epinephrine; Erythrocyte Membrane; Female; Glucose; Glucose Clamp Technique; Glycerol; Humans; Hypertension; Hypoglycemic Agents; Insulin; Insulin Resistance; Ketone Bodies; Kidney; Lactates; Male; Metformin; Middle Aged; Norepinephrine; Placebos; Renin; Sodium | 1996 |
Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Topics: Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Diet, Diabetic; Double-Blind Method; Drug Administration Schedule; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose Clamp Technique; Glycerol; Glycogenolysis; Humans; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Kinetics; Liver; Male; Metformin; Middle Aged; Pioglitazone; Placebos; Thiazolidinediones | 2008 |
18 other study(ies) available for glycerol and metformin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Diurnal pattern of plasma metformin concentrations and its relation to metabolic effects in type 2 (non-insulin-dependent) diabetic patients.
Topics: Alanine; Blood Glucose; Butyrates; Butyric Acid; Circadian Rhythm; Diabetes Mellitus, Type 2; Glycerol; Humans; Lactates; Lactic Acid; Metformin; Pyruvates; Pyruvic Acid | 1990 |
Energy expenditure in non-insulin dependent diabetic subjects on metformin or sulphonylurea therapy.
Topics: Adult; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Energy Metabolism; Fatty Acids, Nonesterified; Female; Glycerol; Humans; Insulin; Male; Metformin; Middle Aged; Norepinephrine; Sulfonylurea Compounds | 1987 |
Mechanism of metformin action in non-insulin-dependent diabetes.
Topics: Amino Acids; Blood Glucose; Diabetes Mellitus, Type 2; Glucagon; Glucose; Glucose Tolerance Test; Glycerol; Humans; Insulin; Kinetics; Lactates; Lactic Acid; Liver; Male; Metformin; Middle Aged | 1987 |
The effects of metformin compared to the effects of phenformin on the lactate production and the metabolism of isolated parenchymal rat liver cell.
Topics: Adenosine Triphosphate; Animals; Carbon Dioxide; Ethanol; Glycerol; Ketone Bodies; Kinetics; Lactates; Lactic Acid; Liver; Male; Metformin; Oxygen Consumption; Phenformin; Proteins; Pyruvates; Pyruvic Acid; Rats; Rats, Inbred Strains | 1984 |
Reduction of the absorption of the fatty acid and glycerol moieties of ingested triglycerides by biguanides: a possible contribution to their anti-obesity, anti-hypertriglyceridaemic and anti-diabetes properties.
Topics: Adipose Tissue; Animals; Carbon Radioisotopes; Fatty Acids; Glycerol; Hypoglycemic Agents; Intestinal Absorption; Liver; Male; Metformin; Obesity; Phenformin; Rats; Rats, Inbred Strains; Time Factors; Triglycerides; Triolein; Tritium | 1982 |
The effect of metformin on adipose tissue metabolism and peripheral blood flow in subjects with NIDDM.
Topics: Adipose Tissue; Analysis of Variance; Blood Glucose; Body Composition; Body Mass Index; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Glycerol; Humans; Hypoglycemic Agents; Insulin; Lactates; Male; Metformin; Middle Aged; Muscle, Skeletal; Reference Values; Regional Blood Flow | 1996 |
Metformin inhibits catecholamine-stimulated lipolysis in obese, hyperinsulinemic, hypertensive subjects in subcutaneous adipose tissue: an in situ microdialysis study.
Topics: Adipose Tissue; Adult; Body Mass Index; Electric Impedance; Epinephrine; Female; Glycerol; Humans; Hyperinsulinism; Hypertension; Hypoglycemic Agents; Kinetics; Lactic Acid; Lipolysis; Male; Metformin; Microdialysis; Norepinephrine; Obesity | 1999 |
The acute effect of metformin on glucose production in the conscious dog is primarily attributable to inhibition of glycogenolysis.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Alanine; Animals; Arteries; Dogs; Fatty Acids, Nonesterified; Female; Gluconeogenesis; Glucose; Glycerol; Glycogen; Hypoglycemic Agents; Kinetics; Lactic Acid; Liver; Male; Metformin; Plasma; Time Factors | 2000 |
Application of (13)C-filtered (1)H NMR to evaluate drug action on gluconeogenesis and glycogenolysis simultaneously in isolated rat hepatocytes.
Topics: Aminoimidazole Carboxamide; Animals; Carbon Isotopes; Cells, Cultured; Gluconeogenesis; Glucose; Glycerol; Glycolysis; Hepatocytes; Lactic Acid; Metformin; Nuclear Magnetic Resonance, Biomolecular; Protons; Rats; Rats, Wistar; Reference Values; Ribonucleotides | 2002 |
Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin.
Topics: Animals; Blood Proteins; Fatty Acids; Fatty Acids, Nonesterified; Glycerol; Heparin; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Rats; Rosiglitazone; Thiazolidinediones; Triglycerides | 2004 |
Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes.
Topics: Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose; Glucose Clamp Technique; Glycerol; Heparin; Humans; Insulin; Insulin Resistance; Male; Metformin; Middle Aged; Pioglitazone; Thiazolidinediones | 2008 |
Mechanisms of metformin inhibiting lipolytic response to isoproterenol in primary rat adipocytes.
Topics: Adipocytes; Adrenergic beta-Agonists; Animals; Carrier Proteins; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Fatty Acids, Nonesterified; Glycerol; Hypoglycemic Agents; Isoproterenol; Lipase; Lipolysis; Metformin; Mitogen-Activated Protein Kinases; Perilipin-1; Phosphoproteins; Rats; Rats, Sprague-Dawley | 2009 |
Impact of a glycogen phosphorylase inhibitor and metformin on basal and glucagon-stimulated hepatic glucose flux in conscious dogs.
Topics: Animals; Blood Glucose; Dogs; Enzyme Inhibitors; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose; Glucose-6-Phosphatase; Glycerol; Glycogen Phosphorylase, Liver Form; Hematocrit; Hypoglycemic Agents; Indoles; Insulin; Lactic Acid; Liver; Liver Glycogen; Male; Metformin; Phenylbutyrates | 2011 |
Aging-associated reductions in lipolytic and mitochondrial proteins in mouse adipose tissue are not rescued by metformin treatment.
Topics: Adenosine Monophosphate; Adipose Tissue; Aging; AMP-Activated Protein Kinases; Animals; Blotting, Western; Down-Regulation; Fatty Acids, Nonesterified; Glucose; Glycerol; Homeostasis; Hypoglycemic Agents; Lipase; Male; Metformin; Mice; Mitochondrial Proteins; p38 Mitogen-Activated Protein Kinases; Phosphoenolpyruvate Carboxykinase (ATP); Protein Kinases; Proteins; Sterol Esterase | 2014 |
Improving oral bioavailability of metformin hydrochloride using water-in-oil microemulsions and analysis of phase behavior after dilution.
Topics: Administration, Oral; Animals; Biological Availability; Emulsions; Ethylene Glycols; Glycerides; Glycerol; Hexoses; Hypoglycemic Agents; Intestinal Absorption; Intestinal Mucosa; Linoleic Acids; Male; Metformin; Oleic Acids; Organic Chemicals; Phase Transition; Polysorbates; Rats, Sprague-Dawley; Solubility; Surface-Active Agents; Water | 2014 |
Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis.
Topics: Animals; Electron Transport Complex IV; Gluconeogenesis; Glucose; Glycerol; Glycerolphosphate Dehydrogenase; Guanidines; Hypoglycemic Agents; Liver; Metformin; Oxidation-Reduction; Phenformin; Pyridines | 2022 |